Elevated glucose concentration changes the content and cellular localization of AMPA receptors in the retina but not in the hippocampus

Neuroscience

Volumn 219, Issue , 2012, Pages 23-32

  Castilho, A F ^a   Liberal, J T ^a   Baptista, F I ^a   Gaspar, J M ^a,b   Carvalho, A L ^b,c   Ambrosio A F ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

AMPA receptors; Diabetic encephalopathy; Elevated glucose

Indexed keywords

GLUCOSE; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; BRAIN NERVE CELL; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; FEMALE; HIPPOCAMPUS; INSULIN DEPENDENT DIABETES MELLITUS; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; RAT; RETINA; RETINA NERVE CELL;

ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; HIPPOCAMPUS; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; NEURONS; RATS; RATS, WISTAR; RECEPTORS, AMPA; RETINA;

EID: 84864022057     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.05.056     Document Type: Article

References (43)

1. Abu-El-Asrar A.M., Dralands L., Missotten L., Al-Jadaan I.A., Geboes K. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 2004, 45:2760-2766.
2. Ambati J., Chalam K.V., Chawla D.K., D'Angio C.T., Guillet E.G., Rose S.J., Vanderlinde R.E., Ambati B.K. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1997, 115:1161-1166.
3. Antonetti D.A., Barber A.J., Bronson S.K., Freeman W.M., Gardner T.W., Jefferson L.S., Kester M., Kimball S.R., Krady J.K., LaNoue K.F., Norbury C.C., Quinn P.G., Sandirasegarane L., Simpson I.A. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006, 55:2401-2411.
4. Baptista F.I., Gaspar J.M., Cristovao A., Santos P.F., Kofalvi A., Ambrosio A.F. Diabetes induces early transient changes in the content of vesicular transporters and no major effects in neurotransmitter release in hippocampus and retina. Brain Res 2011, 1383:257-269.
5. Barber A.J. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:283-290.
6. Barber A.J., Lieth E., Khin S.A., Antonetti D.A., Buchanan A.G., Gardner T.W. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998, 102:783-791.
7. 2+ disregulation in diabetes mellitus. Eur J Pharmacol 2002, 447:201-209.
8. Chabot C., Massicotte G., Milot M., Trudeau F., Gagne J. Impaired modulation of AMPA receptors by calcium-dependent processes in streptozotocin-induced diabetic rats. Brain Res 1997, 768:249-256.
9. Collingridge G.L., Olsen R.W., Peters J., Spedding M. A nomenclature for ligand-gated ion channels. Neuropharmacology 2009, 56:2-5.
10. 2+-permeable AMPA receptors: synaptic plasticity and beyond. Curr Opin Neurobiol 2006, 16:288-297.
11. Daley M.L., Watzke R.C., Riddle M.C. Early loss of blue-sensitive color vision in patients with type I diabetes. Diabetes Care 1987, 10:777-781.
12. Di Luca M., Ruts L., Gardoni F., Cattabeni F., Biessels G.J., Gispen W.H. NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats. Diabetologia 1999, 42:693-701.
13. Diaz E. Regulation of AMPA receptors by transmembrane accessory proteins. Eur J Neurosci 2010, 32:261-268.
14. Dosso A.A., Bonvin E.R., Morel Y., Golay A., Assal J.P., Leuenberger P.M. Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol 1996, 234:300-305.
15. Falsini B., Porciatti V., Scalia G., Caputo S., Minnella A., Di Leo M.A., Ghirlanda G. Steady-state pattern electroretinogram in insulin-dependent diabetics with no or minimal retinopathy. Doc Ophthalmol 1989, 73:193-200.
16. Franceschi M., Cecchetto R., Minicucci F., Smizne S., Baio G., Canal N. Cognitive processes in insulin-dependent diabetes. Diabetes Care 1984, 7:228-231.
17. Gardner T.W., Abcouwer S.F., Barber A.J., Jackson G.R. An integrated approach to diabetic retinopathy research. Arch Ophthalmol 2011, 129:230-235.
18. Gardoni F., Kamal A., Bellone C., Biessels G.J., Ramakers G.M., Cattabeni F., Gispent W.H., Di Luca M. Effects of streptozotocin-diabetes on the hippocampal NMDA receptor complex in rats. J Neurochem 2002, 80:438-447.
19. Gaspar J.M., Baptista F.I., Galvao J., Castilho A.F., Cunha R.A., Ambrosio A.F. Diabetes differentially affects the content of exocytotic proteins in hippocampal and retinal nerve terminals. Neuroscience 2010, 169:1589-1600.
20. Gaspar J.M., Castilho A., Baptista F.I., Liberal J., Ambrosio A.F. Long-term exposure to high glucose induces changes in the content and distribution of some exocytotic proteins in cultured hippocampal neurons. Neuroscience 2010, 171:981-992.
21. Gispen W.H., Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000, 23:542-549.
22. Guyot L.L., Diaz F.G., O'Regan M.H., Song D., Phillis J.W. The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex. Neurosurgery 2001, 48:385-390. discussion 390-391.
23. Hancock H.A., Kraft T.W. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 2004, 45:1002-1008.
24. Hardy K.J., Lipton J., Scase M.O., Foster D.H., Scarpello J.H. Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. Br J Ophthalmol 1992, 76:461-464.
25. Melendez-Ramirez L.Y., Richards R.J., Cefalu W.T. Complications of type 1 diabetes. Endocrinol Metab Clin North Am 2010, 39:625-640.
26. Nakagawa T. The biochemistry, ultrastructure, and subunit assembly mechanism of AMPA receptors. Mol Neurobiol 2010, 42:161-184.
27. Ng Y.K., Zeng X.X., Ling E.A. Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats. Brain Res 2004, 1018:66-72.
28. Reisi P., Alaei H., Babri S., Sharifi M.R., Mohaddes G., Soleimannejad E. Determination of the extracellular basal levels of glutamate and GABA at dentate gyrus of streptozotocin-induced diabetic rats. Pathophysiology 2009, 16:63-66.
29. Ryan C.M., Williams T.M., Finegold D.N., Orchard T.J. Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 1993, 36:329-334.
30. Santiago A.R., Cristovao A.J., Santos P.F., Carvalho C.M., Ambrosio A.F. High glucose induces caspase-independent cell death in retinal neural cells. Neurobiol Dis 2007, 25:464-472.
31. Santiago A.R., Gaspar J.M., Baptista F.I., Cristovao A.J., Santos P.F., Kamphuis W., Ambrosio A.F. Diabetes changes the levels of ionotropic glutamate receptors in the rat retina. Mol Vis 2009, 15:1620-1630.
32. Santiago A.R., Hughes J.M., Kamphuis W., Schlingemann R.O., Ambrosio A.F. Diabetes changes ionotropic glutamate receptor subunit expression level in the human retina. Brain Res 2008, 1198:153-159.
33. Santiago A.R., Pereira T.S., Garrido M.J., Cristovao A.J., Santos P.F., Ambrosio A.F. High glucose and diabetes increase the release of [3H]-d-aspartate in retinal cell cultures and in rat retinas. Neurochem Int 2006, 48:453-458.
34. Santiago A.R., Rosa S.C., Santos P.F., Cristovao A.J., Barber A.J., Ambrosio A.F. Elevated glucose changes the expression of ionotropic glutamate receptor subunits and impairs calcium homeostasis in retinal neural cells. Invest Ophthalmol Vis Sci 2006, 47:4130-4137.
35. Semkova I., Huemmeke M., Ho M.S., Merkl B., Abari E., Paulsson M., Joussen A.M., Plomann M. Retinal localization of the glutamate receptor GluR2 and GluR2-regulating proteins in diabetic rats. Exp Eye Res 2010, 90:244-253.
36. Shinoda K., Rejdak R., Schuettauf F., Blatsios G., Volker M., Tanimoto N., Olcay T., Gekeler F., Lehaci C., Naskar R., Zagorski Z., Zrenner E. Early electroretinographic features of streptozotocin-induced diabetic retinopathy. Clin Exp Ophthalmol 2007, 35:847-854.
37. Sima A.A. Encephalopathies: the emerging diabetic complications. Acta Diabetol 2010, 47:279-293.
38. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 2008, 11:309-317.
39. Trudeau F., Gagnon S., Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 2004, 490:177-186.
40. Washburn M.S., Numberger M., Zhang S., Dingledine R. Differential dependence on GluR2 expression of three characteristic features of AMPA receptors. J Neurosci 1997, 17:9393-9406.
41. Whitmire W., Al-Gayyar M.M., Abdelsaid M., Yousufzai B.K., El-Remessy A.B. Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Mol Vis 2011, 17:300-308.
42. Yamato T., Misumi Y., Yamasaki S., Kino M., Aomine M. Diabetes mellitus decreases hippocampal release of neurotransmitters: an in vivo microdialysis study of awake, freely moving rats. Diabetes Nutr Metab 2004, 17:128-136.
43. Zhang Y., Zhang J., Wang Q., Lei X., Chu Q., Xu G.T., Ye W. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats. Invest Ophthalmol Vis Sci 2011, 52:278-285.